Together, we can turn awareness into action and increase diagnosis, improve treatments, and find a cure.
Raise it. Give it. Get it.
Scroll down
Number of people worldwide affected by celiac disease
Diagnosed patients who still report symptoms while on gluten-free diet
Related family members who also have celiac disease
Increased risk of coronary artery disease/small bowel cancers
A gluten-free diet is not a trend, or a dietary preference.
When you have celiac disease, a strict gluten-free diet is the only currently available treatment for this serious autoimmune disease.
#CeliacDisease #CeliacAwareness
📣 When advocates from across the country spoke together, lawmakers paid attention.
Each year, Senator Blumenthal (CT) spearheads a Senate sign-on letter to the Appropriations Committee calling for support for celiac disease research funding.
This year, thanks to YOUR advocacy, 1,300+ emails were sent to Senate offices, urging Senators to sign their names to the letter supporting celiac disease research. A record-breaking nine Senators signed on—more than ever before.
Each signature represents an agreement to voice support for the celiac disease community at the Senate level.
Read more at the link in our bio.
#CeliacDisease #CeliacAwareness
At Promise Gluten Free, we believe gluten free should never mean compromise. That means bread with real structure, real flavor, and real quality — made to stand on its own, not be a substitute.
We’re excited to be growing in the U.S. and bringing our range of breads to more people who don’t want to choose between gluten free and great bread.
You can now order Proud Sponsor Promise Gluten Free for nationwide delivery at:
👉 shop.promiseglutenfree.us
Here’s to better bread, without compromise ✨
#CeliacAwarenessMonth #PromiseGlutenFree #CeliacDiseaseFoundation #GlutenFreeUSA #GlutenFreeLiving #RealBreadRealFlavor
Do wait times for testing affect accuracy of celiac diagnosis in children?
This year at DDW, Kaitlyn Weix from the Medical College of Wisconsin presented on whether wait time to initial gastroenterology (GI) evaluation impacts diagnostic accuracy for pediatric celiac disease.
#CeliacDisease #CeliacResearch
A major step toward clearer gluten labeling.
At #CCFL49 in Ottawa, the Codex Committee on Food Labelling agreed to move forward updated international guidance for Precautionary Allergen Labelling — the “may contain” statements that can appear on food labels — for final adoption.
Importantly, the guidance includes a 4 mg gluten reference dose for cereals containing gluten. This does not change the gluten-free standard. Foods labeled “gluten-free” must still contain less than 20 ppm gluten.
The Celiac Disease Foundation helped make this progress possible by working to ensure that gluten cross-contact is addressed through celiac-specific science and that the needs of people with celiac disease remain part of global food labeling discussions.
This work matters globally, and it matters in the United States. The U.S. does not currently have a formal precautionary allergen labeling framework for gluten, and the science advanced through Codex can help inform future FDA discussions and strengthen U.S. gluten-free labeling rules.
We are grateful to AOECS, Coeliac UK, Celiac Canada, ISSCD’s Gluten Safety and Standards Committee, FAO/WHO experts, regulators, and advocacy partners around the world whose collaboration helped advance this important milestone.
Pictured at CCFL49: Marilyn Geller, CEO of the Celiac Disease Foundation; Floris van Overveld, Chair of AOECS; and Melissa Secord, National Executive Director of Celiac Canada.
Read more at the link in bio.
Don’t Miss this Celiac Disease Awareness Game at Tropicana Field!
Join the Tampa Bay Rays and the Los Angeles Angels on May 29th at 7:10pm EDT to celebrate Celiac Disease Awareness Night. With a special ticket package purchase fans can enjoy a seat at the game AND a Rays Hat! 🧢
Get your tickets at the link in bio.
#CeliacDisease #CeliacDiseaseAwarenessMonth
Are you hoping for better treatment options for celiac disease one day? Clinical trials are happening right now!
AVALON is a clinical trial assessing an investigational drug designed to promote tolerance to gluten. Learn more and see if you qualify at link in bio.
Eligibility Criteria:
- Age 18–70
- Biopsy-confirmed celiac disease
- Have been on a gluten-free diet for 12+ months
- US resident
Additional eligibility criteria apply.
#CeliacDisease #CeliacAwareness #HealthResearch
We`re preparing the healthcare system for the first generation of celiac disease therapies. Are YOU ready?
On June 12th, the Celiac Disease Foundation and the Society for the Study of Celiac Disease are hosting a one-day virtual summit where experts will examine the policy infrastructure required to bring future treatments to patients efficiently and equitably.
Register today at the link in bio to join leading clinicians, researchers, policymakers, health economists, industry leaders, and patient advocates in this important discussion for the future of celiac disease patients!
#CeliacDisease #Celiac
